GSK shares hit as Advair generic threat grows in US – Chicago Tribune

GSK shares hit as Advair generic threat grows in US
Chicago Tribune
Chances of cheaper versions of the $8 billion-a-year seller being launched in the world's biggest market were increased by a draft guidance document from the Food and Drug Administration (FDA) setting out requirements for generic versions of the
UPDATE 1-GSK shares hit as Advair generic threat grows in U.S.CNBC.com
GSK shares hit as Advair generics edge closer in USYahoo!7 News

all 8 news articles »

View full post on world asthma day – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *